UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy
Shots:
- UCB invested $29.3M in Nile and as majority shareholder- will be the Board of Directors of Nile with future opportunities to acquire insights and data from Nile’s platform
- Nile is developing a digital epilepsy care management platform and bringing together data to make the epilepsy journey predictable. The platform consists of patient app and HCP portal & is anticipated to be commercially available in 2021
- Nile’s platform will serve as a digital extension of the HCPs with an aim of shortening the path to optimal treatment
Ref: UCB | Image: UCB
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com